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Trends in Treated Drug Misuse
in the Western Health Board Area1
Information on problem drug use is collected by the National Drug Treatment
Reporting System (NDTRS). The NDTRS is an epidemiological database on treated drug
misuse. It was established in 1990 in the Greater Dublin Area only. In 1995 it was
extended to other parts of the country, including the Western Health Board (WHB)
area. The objectives of the NDTRS are to provide reliable information on the number
and characteristics of people who are treated for problem drug use, and to examine
trends and patterns of problem drug use. It provides information relevant to the health
consequences and social implications of drug misuse and contributes to an
understanding of the epidemiology of drug misuse in Ireland. This series of papers
presents data by regional health board areas. 
NDTRS methodology
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Compliance with the NDTRS requires that a form be completed for each person who
receives treatment for problematic drug use. Data on treated drug misuse are collected
routinely by staff at drug treatment agencies throughout Ireland. At national level
aggregated anonymous data are compiled by the Drug Misuse Research Division (DMRD),
Health Research Board (HRB). 
For the purpose of the NDTRS, treatment is broadly defined as ‘any activity which aims to
ameliorate the psychological, medical or social state of individuals who seek help for their
drug problems’. Treatment may therefore include non-medical (addiction counselling,
group therapy, psychotherapy), as well as medical interventions (detoxification,
methadone substitution programmes).  
The main elements of the reporting system are: 
a) All Treatment Contacts – the reporting of all clients receiving treatment during a given
year, and 
b) First Treatment Contacts – the reporting of the sub-group of clients who have never
previously been treated for problem drug use.
In the case of the ‘all contact’ data there is a possibility of duplication of individuals in the
database, for example, where a person receives treatment at more than one centre. This is
estimated to be small since the introduction of the Misuse of Drugs Regulations in 1998,
whereby precautions are taken to ensure that treatment by way of medical prescription is
available from one source only.   
Drug treatment data are viewed as an indirect indicator of drug misuse and are used at national and
European levels to provide information on the characteristics of clients entering treatment, and patterns
of drug misuse such as types of drugs used and consumption behaviours. They are ‘valuable from a
public health perspective to assess needs, … and to plan and evaluate services’ (EMCDDA, 1998: 23).
Information from the NDTRS is made available to service providers and policy makers and forms an
important element in informing local and national drug policies. Based on NDTRS data a number of local
areas were targeted for special attention in 1996 (Ministerial Task Force, 1996). Initially eleven areas, ten
in Dublin and one in Cork, all of which were characterised by social and economic disadvantage, were
designated as Local Drug Task Force Areas (Ministerial Task Force, 1996). There are now fourteen areas:
twelve in Dublin; one in Cork; and one in Bray (Department of Tourism, Sport & Recreation, 2001). Local
Drug Task Forces were established with the aim of providing strategic local responses in areas where
drug misuse was a serious problem.
In the Government’s Building on Experience. National Drugs Strategy 2001-2008, the role of the NDTRS is
recognised in ensuring that the overall aims of the strategy are met. NDTRS data collection is one of the
actions identified and agreed by Government for implementation by health boards. It is stated that ‘all
treatment providers should co-operate in returning information on problem drug use to the DMRD of
the HRB’ (Department of Tourism, Sport & Recreation, 2001: 118). 
In 1996, in response to the National Health Strategy, the Working Group on Drug Misuse/Medicine Control
was convened in the WHB. The group made a number of recommendations regarding the prevention of
drug misuse (Nic Gabhainn & Comer, 1996). The introduction of the substance misuse prevention
programme On my Own Two Feet2 was recommended for second level schools. Four groups – adolescents
with learning disabilities; patients who attend casualty with alcohol-related injuries; early school leavers;
and teenage girls and women contemplating pregnancy – considered to be specifically at risk, were
targeted for particular attention. A Community Addiction Team was set up in 1996 with the objective of
identifying ‘the extent of the substance misuse problem and to develop local preventative strategies’ (Nic
Gabhainn & Comer, 1996: 1). A report which was commissioned to examine the level of drug use,
prevention policies and needs assessment in relation to service provision in the area, subsequently
became the basis of the development of the WHB drug strategy (Nic Gabhainn & Comer, 1996). A
Regional Drugs Co-ordinator was appointed with the aim of providing a consistent local response to
drug misuse in the WHB; to liase with all service providers, both statutory and voluntary; and to co-
ordinate the planning and evaluation of drug services (http://www.whb.ie).
Another more recent development was the opening of the Health Advice Café in December 2001. This is
an innovative project offering a range of services and facilities for young people (Walsh, 1999). It is a
social health partnership model of prevention, incorporating information, risk assessment, a peer
education programme and a direct-access counselling service. The overall aim is to build in some of the
protective factors to support healthy lifestyles, by allowing the client group to be self-determining in
their choice of support and guidance from project workers. Positive alternatives such as music
workshops, art, dance and sport will be encouraged (Walsh, 1999).
Data for the NDTRS during 2000 were collected by three agencies: all are non-residential centres. The
type of drug treatment provided/availed of was advice/counselling/support (N=14). 
Treatment provision
The Health
Advice Café is
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project offering
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1 Counties Galway, Mayo and Roscommon
2 This programme was developed by the Heath Promotion Unit of the Department of Health & Children and the Psychological Service of the
Department of Education & Science
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Treatment as an indicator of drug misuse
Treated drug misuse
The use of psychoactive substances in the WHB area, especially cannabis, ecstasy and LSD is widespread,
particularly among young people (Nic Gabhainn & Comer, 1996). However, the number of problematic
drug users reported to the NDTRS is relatively low. This could be due in part to reluctance on the part of
people to present for the treatment of drug-related problems - they are less likely to do so where there are
no accessible drug user orientated services provided. In the WHB gaps were identified in service provision
– where there were no direct-access primary care services for drug users and ‘treatment services are seen
as over-stretched, under-resourced and often ineffective’ (Nic Gabhainn & Comer, 1996: 54).
Extent of the problem
In 1999 and 2000 most of those treated in the WHB area were new clients (first contacts) – they were
receiving treatment for problem drug use for the first time ever. The number of first contacts increased
from 4 in 1996 to 13 in 2000 (Table 1b).  
Table 1a. Number of All Treatment Contacts* by treatment area and area of residence of clients,
1996-2000
Year Total treated in WHB WHB residents WHB residents Others treated in Total WHB residents
treated in WHB treated elsewhere WHB treated
1996 11 11 7 0 18
1997 Na Na 2 Na 2
1998 8 7 7 1 14
1999 22 22 10 0 32
2000 14 14 16** 0 30**
* Number of cases, as distinct from individuals, who received treatment for their problem drug use
** Provisional figures due to incomplete returns from the Eastern Regional Health Authority health boards
Na: Not available
Table 1b. Number of First Treatment Contacts* by treatment area and area of residence of 
clients, 1996-2000
Year Total treated in WHB WHB residents WHB residents Others treated in Total WHB residents
treated in WHB treated elsewhere WHB treated
1996 4 4 5 0 9
1997 Na Na 1 Na 1
1998 2 2 1 0 3
1999 13 13 2 0 15
2000 13 13 11** 0 24**
* Number of people who received treatment for the first time ever
** Provisional figures due to incomplete returns from the Eastern Regional Health Authority health boards
Na: Not available
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3 The emphasis of this paper is on the illicit drug use of clients who received treatment between 1996 and 2000, in the catchment area
covered by the WHB (Galway, Mayo and Roscommon)
4 Data from the WHB were not available for 1997
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The number of drug users presenting for treatment3 in the WHB area, and reporting to the NDTRS
increased from 11 in 1996 to 22 in 1999 and fell to 14 in 20004. Except for one person in 1999, all those
who received treatment in the WHB area were from the catchment area (Table 1a). Each year between
1996 and 2000 a number of WHB residents received treatment for problematic drug use elsewhere. In
fact, in 2000 the number receiving treatment elsewhere (N=16) slightly exceeded the number treated in
the area (N=14) (Table 1a).
Table 3a. Main Drug of Misuse of All Treatment Contacts treated in the WHB, 1996-2000
Main Drug of Misuse 1996 1997 1998 1999 2000
N N N N N
Opiates 3 Na 1 6 2
Cocaine 0 Na 0 0 0
Ecstasy 1 Na 1 6 8
Amphetamines 0 Na 0 4 0
Benzodiazepines 2 Na 3 0 1
Volatile Inhalants 0 Na 0 0 0
Cannabis 4 Na 2 6 3
Other substances 1 Na 1 0 0
Total 11 Na 8 22 14
Na: Not available
Table 2b. Socio-demographic characteristics of First Treatment Contacts treated in the WHB, 1996-2000
Characteristics 1996 1997 1998 1999 2000
% Males : % Females 50:50 Na 100:0 92:8 92:8
Mean age (years) 33 Na 35 19 24
Modal age (years) 22 Na 19 19 17
% Under 18 years of age 0 Na 0 23 23
% Living with parent/family 100 Na 50 69 46
% Early school leavers* 0 Na 0 17 0
% Still at school 0 Na 0 0 17
% Employed 75 Na 50 46 46
* Left school before the age of 15 years
Na: Not available
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Table 2a. Socio-demographic characteristics of All Treatment Contacts treated in the WHB, 1996-2000
Characteristics 1996 1997 1998 1999 2000
% Males : % Females 73:27 Na 100:0 77:33 93:7
Mean age (years) 33 Na 33 25 24
Modal age (years) 23 Na 31 19 21
% Under 18 years of age 0 Na 0 18 21
% Living with parent/family 88 Na 25 41 50
% Early school leavers* 20 Na 1 20 0
% Still at school 0 Na 0 0 15
% Employed 11 Na 13 32 43
* Left school before the age of 15 years
Na: Not available
Information on patterns of drug use among treated populations, such as the types of drugs used, how
they are taken, and whether in combination with other drugs, can be useful in assessing and planning
drug treatment services. Unfortunately very little data on treated drug misuse are available from the WHB
area. Because numbers are low, it is therefore very difficult to review trends in the WHB between 1996
and 2000. Data returns to the NDTRS are presented below in Tables 2a to 6b. 
Table 3b. Main Drug of Misuse of First Treatment Contacts treated in the WHB, 1996-2000
Main Drug of Misuse 1996 1997 1998 1999 2000
N N N N N
Opiates 1 Na 0 1 2
Cocaine 0 Na 0 0 0
Ecstasy 1 Na 1 5 8
Amphetamines 0 Na 0 2 0
Benzodiazepines 1 Na 0 0 1
Volatile Inhalants 0 Na 0 0 0
Cannabis 1 Na 1 5 2
Other substances 0 Na 0 0 0
Total 4 Na 2 13 13
Na: Not available
Table 4a. Opiate as a Main Drug of Misuse for All Treatment Contacts treated in the WHB, 1996-2000
Main Drug / Route 1996 1997 1998 1999 2000
of Administration N N N N N
Heroin 1 Na 1 5 1
of whom:
injected 1 Na 0 2 0
smoked 0 Na 1 1 1
other route 0 Na 0 2 0
Other Opiates 2 Na 0 1 1
Total 3 Na 1 6 2
Na: Not available
Table 4b. Opiate as a Main Drug of Misuse for First Treatment Contacts treated in the WHB, 
1996-2000
Main Drug / Route 1996 1997 1998 1999 2000
of Administration N N N N N
Heroin 0 Na 0 1 1
of whom:
injected 0 Na 0 1 0
smoked 0 Na 0 0 1
other route 0 Na 0 0 0
Other Opiates 1 Na 0 0 1
Total 1 Na 0 1 2
Na: Not available
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Table 6a. Risk Behaviours of All Treatment Contacts treated in the WHB, 1996-2000
Risk Behaviours 1996 1997 1998 1999 2000
Mean age of initial drug use (years) 15 Na 18 16 15
Mean age 1st injected (years) --** Na --** 21 --**
Ever Injected  N 1 Na 0 7 0
of whom:
‘ever shared’  N 0 Na 0 3 0
‘currently injecting’  N 0 Na 0 3 0
‘currently sharing’  N 0 Na 0 0 0
Na: Not available
** Not applicable
Table 6b. Risk Behaviours of First Treatment Contacts treated in the WHB, 1996-2000
Risk Behaviours 1996 1997 1998 1999 2000
Mean age of initial drug use (years) 16 Na 13 16 15
Mean age 1st injected (years) --** Na --** --** --**
Ever Injected  N 0 Na 0 1 0
of whom:
‘ever shared’  N 0 Na 0 0 0
‘currently injecting’  N 0 Na 0 1 0
‘currently sharing’  N 0 Na 0 0 0
Na: Not available
** Not applicable
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Table 5b. Secondary Drug of Misuse of First Treatment Contacts treated in the WHB, 1996-2000
Secondary Drug of 1996 1997 1998 1999 2000
Misuse N N N N N
No second drug 0 Na 1 6 3
Opiates 0 Na 0 0 0
Cocaine 1 Na 0 0 2
Ecstasy 0 Na 0 1 1
Amphetamines 1 Na 1 3 0
Benzodiazepines 1 Na 0 0 1
Volatile Inhalants 0 Na 0 0 0
Cannabis 0 Na 0 3 4
Alcohol 1 Na 0 0 2
Other substances 0 Na 0 0 0
Total 4 Na 2 13 13
Na: Not available
Table 5a. Secondary Drug of Misuse of All Treatment Contacts treated in the WHB, 1996-2000
Secondary Drug of 1996 1997 1998 1999 2000
Misuse N N N N N
No second drug 0 Na 4 9 3
Opiates 1 Na 1 0 0
Cocaine 2 Na 0 3 2
Ecstasy 0 Na 0 3 2
Amphetamines 1 Na 1 3 0
Benzodiazepines 1 Na 1 0 1
Volatile Inhalants 0 Na 0 0 0
Cannabis 1 Na 1 4 4
Alcohol 4 Na 0 0 2
Other substances 1 Na 0 0 0
Total 11 Na 8 22 14
Na: Not available
Figures 1a and 1b provide a comparison of the rates of treated drug misuse among residents in different
health board areas of Ireland for all and first treatment contacts respectively5. As the majority of people
treated for problem drug use are in the 15-39 year age group, the rates were based on this age group of
the population in each health board area. It is immediately obvious that in the ERHA health board areas
(formerly EHB) the rate is much higher than in other regions of the country. However, there is not great
variation in regional trends. In all cases the trend shows an increase in those presenting to drug
treatment services (Figure 1a).   
There was an upward trend in first treatment contacts between 1996 and 2000 in all regions (Figure 1b).
Increased provision of services at individual health board level is of course a factor that must be borne in
mind when considering such trends. Where there are accessible drug user oriented services provided,
people are more likely to approach them. However, it would appear that the upward trends also indicate
a real increase in drug misuse.  
Regional trends
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Figure 1a. Trends in All Treatment Contact rates for 15 - 39 year olds by Health Board of 
Residence, 1996-2000*. Rates per 10,000 population **
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Figure 1b. Trends in First Treatment Contact rates for 15 - 39 year olds by Health Board of 
Residence, 1996-2000*. Rates per 10,000 population **
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* Trends for 1996-1999 only in the EHB due to incomplete returns for 2000
** Population figures for each health board are based on the Census for Population 1996, Central Statistics Office
* Trends for 1996-1999 only in the EHB due to incomplete returns for 2000
** Population figures for each health board are based on the Census for Population 1996, Central Statistics Office
Year
5 1999 is the latest date for which ERHA data are available
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• Data from the NDTRS provide a profile of drug users presenting to the treatment services. This gives planners and service providers
an insight into the number and type of clients availing of treatment services.
• Data on clients receiving treatment for the first time can indicate, over time, changing patterns and trends in problematic drug use.
It is thus possible to distinguish new populations of drug users coming for treatment, from more long term chronic drug users.
• A particular benefit of this database is that it provides a foundation for carrying out other more detailed investigations. The value
increases over time if data are collected systematically for a number of years. Examples include studies of changes in behaviour
patterns in different subgroups, or comparisons with samples of untreated drug users. The DMRD welcomes collaborative research
using the NDTRS database.
• The DMRD will provide to the agency, if required, an analysis of returns made to the NDTRS. This can be very useful to the agency
for end of year appraisal of clients, or for research purposes.
Value of NDTRS
